| James A Gallo, MD | |
|
828 Toll Gate Rd, Warwick, RI 02886-2721 | |
| (401) 615-3043 | |
| Not Available |
| Full Name | James A Gallo |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 828 Toll Gate Rd, Warwick, Rhode Island |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801978622 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 07683 (Rhode Island) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| James A Gallo, MD 828 Toll Gate Rd, Warwick, RI 02886-2721 Ph: (401) 615-3043 | James A Gallo, MD 828 Toll Gate Rd, Warwick, RI 02886-2721 Ph: (401) 615-3043 |
News Archive
Decoding the complete DNA of cancer patients is giving scientists at Washington University School of Medicine in St. Louis a clearer picture of the complexity of the disease and allowing them to see intriguing and unexpected genetic relationships among patients.
Researchers at UConn Health used stem cells derived from patients with Angelman syndrome to identify the underlying cellular defects that cause the rare neurogenetic disorder, an important step in the ongoing search for potential treatments for Angelman and a possible cure.
When you're ordering the new Starbucks "trenta" you're not only getting a massive drink (31 ounces) but massive calories (up to 600) - with the potential to pack on more than 60 extra pounds in one year.
Researchers at the University of California, San Diego School of Medicine, in partnership with the California Institute for Regenerative Medicine (CIRM) and Celgene Corporation, a New Jersey-based biopharmaceutical company, have launched a phase 1 human clinical trial to assess the safety and efficacy of a novel monoclonal antibody for patients with chronic lymphocytic leukemia (CLL).
Akela Pharma, Inc., a drug development company with its lead product, Fentanyl TAIFUN, being developed for the treatment of breakthrough cancer pain and the company's wholly owned subsidiary, PharmaForm, a leading specialty contract service provider in the area of pharmaceutical dosage form development and manufacturing, today announced its financial results for the three months and year ended March 31, 2011.
› Verified 3 days ago
Juan Carlos Canton, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 390 Toll Gate Road, Warwick, RI 02886 Phone: 401-737-0005 Fax: 401-737-9880 | |
Neil Labove, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 176 Tollgate Road, Suite 202, Warwick, RI 02886 Phone: 401-738-2325 | |
Dr. Ethan H Kisch, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 75 Lambert Lind Hwy, 120-100, Warwick, RI 02886 Phone: 401-681-4274 Fax: 401-681-4285 | |
Dr. Tasia Henderson, DNP Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 120 Lavan St Ste 1, Warwick, RI 02888 Phone: 401-808-6421 Fax: 401-259-3028 | |
Marjorie Smith, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 455 Toll Gate Rd, Warwick, RI 02886 Phone: 401-737-7010 Fax: 401-736-4546 | |
Dr. Sandhya M Patel, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2756 Post Rd, Warwick, RI 02886 Phone: 401-738-4229 | |
Maurizio Zambenedetti, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 33 College Hill Rd, 29c, Warwick, RI 02886 Phone: 401-822-4673 Fax: 401-822-4676 |